The efficacy and tolerability of Nasaleze has been well documented in extensive and rigorous trials. The powder has been tested both as a preventative approach to attacks of hayfever and also as a treatment to the symptoms of allergic reactions.
Studies have demonstrated that Nasaleze:
- Reduces symptoms in up to 90% of sufferers
- Significantly reduces the effects of seasonal allergic rhinitis
- Substantially improves the rate of nasal mucus clearance and PNIFR
- Safe for children to use
- Reduces symptoms of house dust mite allergy
- No side effects and is non habit forming
Clinical Trial document
All clinical trial data is available.
Click here to download the full PDF